Research Community
Collaborative Research Network
The ASAP Collaborative Research Network (CRN) is an international, multidisciplinary, and multi-institutional network of collaborating investigators who are working to address high-priority research questions to spark new discoveries for Parkinson’s disease. Each CRN team supports productive collaborations, includes diverse talents, and embraces the values of openness and transparency to accelerate outcomes and the impact of findings.
Explore CRN
Global Parkinson's Genetics Program
The Global Parkinson’s Genetics Program (GP2) is an ambitious resource program to understand the genetic architecture of Parkinson’s disease through genotyping over 250,000 volunteers around the world – helping to ensure ancestral diversity is included in Parkinson’s disease-related genetic research and making Parkinson’s genetics globally relevant. GP2’s commitment to serving underrepresented populations extends to providing tools, trainings, and other resources to Parkinson’s disease researchers around the world.
Explore GP2
Parkinson’s Progression Markers Initiative
The Parkinson’s Progression Markers Initiative (PPMI) is a landmark observational study designed to support worldwide strategies for investigating and defining biomarker signatures of Parkinson’s disease risk, onset, and progression. PPMI makes its data set and biorepository – the most robust in Parkinson’s to date – available to academia and industry to accelerate breakthroughs.
Explore PPMIConsortia
Aligning Science Across Parkinson’s is a member of various organizations. Membership with these consortia allows us to work together with the research community to accelerate scientific advances by fostering a collaborative and open approach to research.
Funding Opportunities
We continue to drive the Parkinson’s research field forward by offering new funding opportunities to expand the tools and resources the community can leverage, as well as additional ways for the research community to connect.
